TCBP:NASDAQ, TC Biopharm (Holdings) Plc

TCBP stock overview

TC Biopharm (Holdings) Plc (TCBP:NASDAQ) closed at $0.500 on March 19, 2026, unchanged on the day. The stock trades 99.9% below its 52-week high of $523.20 and 525.0% above its 52-week low of $0.080. TC Biopharm (Holdings) Plc is part of the Health Care sector.

Key figures

Price

$0.500

Day change

0.00%

Volume

5,896,474

Average volume

360,643

Market cap

256K+

52-week range

$0.080 – $523.20

50-day average

$3.18

200-day average

$48.27

Price action over the past year

In 252 trading sessions since October 23, 2025, TCBP closed higher on 0 days (0%). Its best day was October 23, 2025 (0.00%) and its worst was October 23, 2025 (0.00%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 252 times.

About TC Biopharm (Holdings) Plc

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Similar stocks

• INLF:NASDAQ
• GCTK:NASDAQ
• SXTC:NASDAQ
• XXII:NASDAQ
• SPRC:NASDAQ
• LABT:NASDAQ
• NXTS:NASDAQ
• SCNI:NASDAQ

Find more stocks like TCBP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.